Nuclear Cardiology is a specialized field of cardiology that uses noninvasive imaging techniques involving radioactive tracers to evaluate the heart's structure, function, and blood flow. It provides critical insights into diagnosing, managing, and treating various cardiac conditions. Nuclear Cardiology is a diagnostic modality for assessing cardiac function. This examination provides images of the heart muscle contraction, movement, and rhythm, helping doctors diagnose and differentiate various heart diseases more accurately. 

What is Nuclear Cardiology?

Nuclear cardiology is a diagnostic cardiac imaging tool for assessing cardiac muscle function abnormalities using radiopharmaceuticals. These radiopharmaceuticals are injected into a vein and emit radiation energy, allowing external diagnostic equipment to delineate abnormalities within the heart without performing a tissue biopsy. Generally, patients may be wary of radiation exposure; however, for diagnostic imaging, patients receive only a minuscule radiation dose, which decays and is eliminated quickly from the body, making it safe and non-hazardous to organs like the kidneys or liver. Nuclear Cardiology examinations can diagnose various heart diseases and heart muscle conditions.

 Why should you come for a Nuclear Cardiology examination at MedPark?

• Diagnosis by skillful nuclear cardiologists with over 25 years of experience

• Collaboration with doctors from other specialties, providing consultation and access to relevant examination and treatment data for accurate diagnosis and treatment.

• Experienced nuclear medicine technologists with proficiency in operating nuclear cardiology instrumentation and equipment

• Efficient and precise diagnosis facilitated by advanced medical equipment and tools.

• Medical staff are ready to treat abnormal heart conditions promptly upon diagnosis.

• The cardiac rehabilitation physician team, physical therapists, and nutritionists are available to provide post-treatment care and promote heart health for improved quality of life.

Nuclear cardiology procedure

Myocardial Perfusion GATED SPECT-CT Stress-Rest: utilizing Tc-99m MIBI to locate the ischemic muscle regions, which involves comparing two sets of imaging scans performed during the following two stages:

• Resting stage

• Exercise stage: A patient either walks on a treadmill or receives a pharmacologic agent to stimulate heart contractions, mimicking conditions during exercise.

Compare the test results of both stages to locate the site with reduced perfusion and to consider suitable treatment approaches.

Potential risks and complications of nuclear cardiology imaging

Nuclear cardiology tests pose minimal risks, complications, or danger from radiation. The harms of radioactive materials generally are proportional to the amount of radioactive material used in the test. Typically, a dose of radioactive material used in a nuclear cardiology diagnostic test is less than in a therapeutic procedure and leaves no residual radioactive material. When using stimulating pharmacologic agents in place of exercise on a treadmill to simulate heart activity during exercise, potential side effects may include low blood pressure, dizziness, nausea, and vomiting. These symptoms are temporary and not harmful. Nevertheless, nuclear cardiology tests are not for pregnant women or those who suspect they are pregnant, given that radiation exposure can harm the fetus.

Frequently Asked Questions

• Is the radiopharmaceutical used in Nuclear Cardiology examinations harmful?
  No, it is not hazardous and does not affect other organs. Medical statistics show that radiation-induced cancer mortality is about 0.05% (1 in 2,000), while the risk from other factors could be as high as 25% (1 in 4).

• Radioactive substances employed in nuclear cardiology pose no threat or harm to surrounding organs. Medical data indicates that the likelihood of cancer-related mortality from these substances stands at a mere 0.05 percent (1 in 2,000 individuals), significantly lower than the 25 percent (1 in 4) risk posed by other causes.

• How long do the radiopharmaceutical agents used in Nuclear Cardiology imaging require for complete decay?
  Approximately 24 hours, depending on the type of radiopharmaceutical used.

Related Package